Seneca Therapeutics, Inc (STI)

Seneca Therapeutics product - SVV-001 - is an extremely versatile virus able to make resistant tumors susceptible again and to deliver genes into TEM8 tumors

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded February 2018
  • Employees 4
  • Incorporation Type C-corp
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free